ORC Expert Advisory Services ORC International

  home    |    find an expert    |    request an expert    |    join our network    |    about us     expert login  
Expert Consulting and Expert Witness Services
  search tips 
Share this page:  Send to LinkedIn Send to Facebook Tweet This Email Print

 Expert  727983

Expert in Global Reproductive Health, Contraceptive R&D and Translational Research

Available for your Consulting and Expert Witness Needs

Texas (TX)
Education Work History Career AccomplishmentsPublicationsConsulting Services Expert Witness

Summary of Expertise:

Listed with other top experts in: 

Expert has been a Professor in the Department of Obstetrics and Gynecology (OB-GYN) at Eastern Virginia Medical School since 1995 and the director of the Consortium for Industrial Collaboration in Contraceptive Research (CICCR) project of CONRAD. He has expertise in reproductive biology and fertility regulation. He obtained his Ph.D. in 1962 and his Sc.D. in 1979 from the U. of Cambridge, UK, and his MBA in 1984 from the U. of Texas at San Antonio. He was elected a Fellow of the UK Society of Biology in 1979. Expert has served as a technical officer at Imperial Chemical Industries Ltd. (now AstraZeneca PLC), and as a scientific officer in the WHO Special Programme of Research, Development, and Research Training in Human Reproduction. From 1979 to 1993, he was first Associate, then full Professor and Chief, Division of Reproductive Research, in the OB-GYN Department at the U. of Texas Health Science Center at San Antonio, and from 1993 to 1995, in the Department of OB-GYN and the Department of Cell Biology at Baylor College of Medicine. Expert has been a consultant on reproductive biology and contraception to many national and international organizations.

He was the lead-discoverer of Tamoxifen, widely used for the treatment of breast cancer. He has published extensively (196 papers, chapters and reviews) on reproductive biology and contraception, including Birth Control Technologies: Prospects by the year 2000 (1983). He has served on two Institute of Medicine Committees which produced the reports: Contraceptive Research and Development: Looking to the Future (1996) and New Frontiers in Contraceptive Research: A Blueprint for Action (2004).


barrier contraception


birth control


ovulation inhibition


postcoital contraception


reproductive sterilization

Show Secondary and Basic Areas of Expertise
Expert may consult nationally and internationally, and is also local to the following cities: Houston, Texas;  Pasadena, Texas;  Beaumont, Texas;  College Station, Texas;  Baytown, Texas;  Bryan, Texas;  Sugar Land, Texas;  Victoria, Texas;  Port Arthur, Texas;  and Galveston, Texas.

Year   Degree   Subject   Institution   Honors
1984   MBA   Management   University of Texas at San Antonio  
1979   ScD   Contributions to Advancement of Science   University of Cambridge, UK  
1962   PhD   Reproductive Physiology   University of Cambridge, UK   Magdalene College Research Fellow
1958   Post Graduate Diploma (equivalent to MS)   Animal Science   University of Reading, UK   Agricultural Food Products Prize
1957   BA   Agriculture   University of Cambridge, UK   Woodman Prize for Chemistry of Foods

Work History:
Years   Employer   Department   Title   Responsibilities

1995 to 2010


Eastern Virginia Medical School




Professor Emeritus


He has been Director of the Consortium for Industrial Collaboration in Contraceptive Research, a program of CONRAD.

1993 to 1995


Baylor College of Medicine


OB-GYN and Cell Biology




He was Director of Reproductive Research in the Reproductive Endocrinology and Infertility Division

1975 to 1993


Univerity of Texas Health Science Center at San Antonio


OB-GYN and Physiology


Associate to Full Professor


He was Chief, Reproductive Research Division

1972 to 1975


World Health Organization


Human Reproduction Programme




He was a manager of three Task Forces working different approaches to novel contraceptives.

1964 to 1972


Worcester Foundation For Experimental Biology, Shrewsbury MA



Postdoc to Senior Scientist


He was a postdoc fellow with MC Chang and then obtained his own NIH funding, including a Research Career Develoment Award.

1961 to 1965


ICI Pharmaceuticals (now AstraZeneca)




Technical Officer


He was charged with discovery of new contraceptives. His work resulted in discovery of Tamoxifen, a potent antiestrogen useful for breast cancer therapy.

Career Accomplishments:

He recived a Research Career Development Award from NICHD.


Fellow of Society of Biology, UK Texas Real Estate Broker's License

Professional Appointments

Associate Editor for Contraception, Reviewer for many Journals (Endocrinology, Theriogenology, Endocrine, Fertility and Sterility). Reviewer for NIH - Loan Repayment Program, Innovative Research Applications and Ad Hoc Panels.

Publications and Patents Summary

He has 148 publications in peer-reviewed Journals and 48 Chapters and reviews. he has 4 patents and one book on Birth Control Technologies..

Selected Publications and Publishers  
 - Human Reproduction  
 - Journal of Clinical Investigation  
 - Contraception  
 - Sexuality, Reproduction and Menopause  
 - University of Texas Press and Heinemann Medical Books, LTD.  

Government Experience:
Years   Agency   Role   Description
1988 to   USAID   Member of Review Team   He was a member of review team evaluating an USIAD program
1993 to   USA   Member of review Team   He was a member of review team evaluating an USIAD program
1992 to   NIH   Member of review panel   Reviewer Ad Hoc Study Section to review Perinatal Emphasis Research Center applications
1991 to   NIH   Chairman of Panel   Chair NIH Special Study Section to review applications for Cooperative Program of Contraceptive Research and Development Centers

Consulting Services:
Selected Consulting Examples:
  • He has acted as a tecnical consultant for Schering Plough (2009), Schering AG,(joint reseacrh program (2004-2008), Wyeth-Ayerst (1994), GD Searle and Co. (1987-1992) and AstraZeneca (1981-1991) concerning contraceptive R&D.
Click the green button above to contact Expert for a free initial screening call regarding your expert consulting needs.  Expert is available for consulting to corporate, legal and government clients.  Remember, your initial screening call to speak with Expert is free.

Expert Witness:
Expert Witness Experience Summary:
He has been deposed and given testimony 4 times in relation to lawsuits seeking to invalidating the Tamoxifen patent.
Recent Litigation Client Requests:
  • Expert in birth control products for consulting on birth control product liability case.
  • Expert for consulting on future diagnosis of Tamoxifen exposure.
Click the green button above to contact Expert for a free initial screening call regarding expert testimony, litigation consulting and support, forensic services, or any related expert witness services.  A few litigation needs include product liability, personal injury, economic loss, intellectual property (patent, trademark, trade secret, copyright), and insurance matters.  Remember, your initial screening call to speak with Expert is free.

International Experience:
Years   Country / Region   Summary
1972 to 1975   Switzerland   He worked as a Slentist at WHO, Geneva in the HR program to develop novel contraceptives
1961 to 1966   UK   He was employed as a technical Oficer to discover novel contraceptive agents

Language Skills:
Foreign Language  

Additional Skills and Services:

He has given innumerable invited and research lectures and also lectures to medical and dental students.

Other Skills and Services

He has served as a consultant for a variety of government agencies (NIH, NSF, USAID, Fogarty Center), foundations (Andrew W. Mellon) and industry.


Need the right expert?  We can help!

home       find an expert       request an expert       join our network       about us

Intota is now ORC Expert Advisory Services